JP2007504176A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007504176A5 JP2007504176A5 JP2006525025A JP2006525025A JP2007504176A5 JP 2007504176 A5 JP2007504176 A5 JP 2007504176A5 JP 2006525025 A JP2006525025 A JP 2006525025A JP 2006525025 A JP2006525025 A JP 2006525025A JP 2007504176 A5 JP2007504176 A5 JP 2007504176A5
- Authority
- JP
- Japan
- Prior art keywords
- tetrahydro
- guanidine
- rac
- quinazolin
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 thiadiazanaphthalene Chemical compound 0.000 claims 25
- 150000001875 compounds Chemical class 0.000 claims 22
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 7
- 125000004432 carbon atom Chemical group C* 0.000 claims 6
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 239000001257 hydrogen Substances 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- XCZPDOCRSYZOBI-UHFFFAOYSA-N 5,6,7,8-Tetrahydroquinoxaline Chemical compound C1=CN=C2CCCCC2=N1 XCZPDOCRSYZOBI-UHFFFAOYSA-N 0.000 claims 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 claims 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical class N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 claims 2
- 125000003282 alkyl amino group Chemical group 0.000 claims 2
- 125000005115 alkyl carbamoyl group Chemical group 0.000 claims 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 2
- 125000004414 alkyl thio group Chemical group 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims 2
- 125000005116 aryl carbamoyl group Chemical group 0.000 claims 2
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims 2
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims 2
- 125000001589 carboacyl group Chemical group 0.000 claims 2
- 125000006310 cycloalkyl amino group Chemical group 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000004438 haloalkoxy group Chemical group 0.000 claims 2
- 125000001188 haloalkyl group Chemical group 0.000 claims 2
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 2
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 229940127557 pharmaceutical product Drugs 0.000 claims 2
- 125000003373 pyrazinyl group Chemical group 0.000 claims 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- JZVATIQSUFESHS-UHFFFAOYSA-N 1,2,3,4-tetrahydro-1,2,3-benzotriazine Chemical compound C1=CC=C2CNNNC2=C1 JZVATIQSUFESHS-UHFFFAOYSA-N 0.000 claims 1
- ZCZVGQCBSJLDDS-UHFFFAOYSA-N 1,2,3,4-tetrahydro-1,8-naphthyridine Chemical compound C1=CC=C2CCCNC2=N1 ZCZVGQCBSJLDDS-UHFFFAOYSA-N 0.000 claims 1
- BHKODZGDVUUACI-UHFFFAOYSA-N 1,2,3,4-tetrahydropyrido[3,2-d]triazine Chemical compound C1=CN=C2CNNNC2=C1 BHKODZGDVUUACI-UHFFFAOYSA-N 0.000 claims 1
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical class N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 claims 1
- REOZEPNIJZQMLX-UHFFFAOYSA-N 1h-cyclohepta[b]pyrazine Chemical compound C1=CC=CC=C2NC=CN=C21 REOZEPNIJZQMLX-UHFFFAOYSA-N 0.000 claims 1
- HCLXLZGAYCTHQJ-UHFFFAOYSA-N 1h-cyclohepta[b]pyridine Chemical class C1=CC=CC=C2NC=CC=C21 HCLXLZGAYCTHQJ-UHFFFAOYSA-N 0.000 claims 1
- BKARLPMXLIRRID-UHFFFAOYSA-N 1h-cyclohepta[d]pyrimidine Chemical compound C1=CC=CC=C2NC=NC=C21 BKARLPMXLIRRID-UHFFFAOYSA-N 0.000 claims 1
- KEOWKZFSSBVUIW-UHFFFAOYSA-N 1h-cyclopenta[b]pyrazine Chemical compound C1=CNC2=CC=CC2=N1 KEOWKZFSSBVUIW-UHFFFAOYSA-N 0.000 claims 1
- LTFBFZBWUKWXID-UHFFFAOYSA-N 1h-cyclopenta[d]pyrimidine Chemical compound N1=CNC2=CC=CC2=C1 LTFBFZBWUKWXID-UHFFFAOYSA-N 0.000 claims 1
- XWIYUCRMWCHYJR-UHFFFAOYSA-N 1h-pyrrolo[3,2-b]pyridine Chemical class C1=CC=C2NC=CC2=N1 XWIYUCRMWCHYJR-UHFFFAOYSA-N 0.000 claims 1
- LJGKMJWLEQYVEG-UHFFFAOYSA-N 2,3,4,4a-tetrahydro-1h-cyclohepta[d]triazine Chemical compound C1=CC=CC2CNNNC2=C1 LJGKMJWLEQYVEG-UHFFFAOYSA-N 0.000 claims 1
- JKWQHCSGMTWRIQ-UHFFFAOYSA-N 2,3-dihydro-1h-pyrrolo[3,2-b]pyridine Chemical compound C1=CC=C2NCCC2=N1 JKWQHCSGMTWRIQ-UHFFFAOYSA-N 0.000 claims 1
- PJVQPPHJEYPUDB-UHFFFAOYSA-N 2,3-dihydrofuro[3,2-b]pyridine Chemical compound C1=CC=C2OCCC2=N1 PJVQPPHJEYPUDB-UHFFFAOYSA-N 0.000 claims 1
- YBMFFLZLOZRFDD-UHFFFAOYSA-N 2,3-dihydrothieno[3,2-b]pyridine Chemical compound C1=CC=C2SCCC2=N1 YBMFFLZLOZRFDD-UHFFFAOYSA-N 0.000 claims 1
- DZVMZYRUBJDTPQ-UHFFFAOYSA-N 2-(4,5-dimethyl-5,6,7,8-tetrahydroquinazolin-2-yl)guanidine Chemical compound NC(=N)NC1=NC(C)=C2C(C)CCCC2=N1 DZVMZYRUBJDTPQ-UHFFFAOYSA-N 0.000 claims 1
- AQIXPPDRNFNPRW-UHFFFAOYSA-N 2-(4,6-dimethyl-5,6,7,8-tetrahydroquinazolin-2-yl)guanidine Chemical compound NC(=N)NC1=NC(C)=C2CC(C)CCC2=N1 AQIXPPDRNFNPRW-UHFFFAOYSA-N 0.000 claims 1
- HRCXBKBEBGJMDJ-UHFFFAOYSA-N 2-(4,8-dimethyl-5,6,7,8-tetrahydroquinazolin-2-yl)guanidine Chemical compound N1=C(NC(N)=N)N=C2C(C)CCCC2=C1C HRCXBKBEBGJMDJ-UHFFFAOYSA-N 0.000 claims 1
- IXDXFXQFNMXQQU-UHFFFAOYSA-N 2-(4-methyl-5,6,7,8,9,10-hexahydrocycloocta[d]pyrimidin-2-yl)guanidine Chemical compound C1CCCCCC2=C1N=C(N=C(N)N)N=C2C IXDXFXQFNMXQQU-UHFFFAOYSA-N 0.000 claims 1
- ATKAGXXVMZWYGM-UHFFFAOYSA-N 2-(4-methyl-5,6,7,8-tetrahydroquinazolin-2-yl)guanidine Chemical compound C1CCCC2=C1N=C(N=C(N)N)N=C2C ATKAGXXVMZWYGM-UHFFFAOYSA-N 0.000 claims 1
- NIULILZCZJKURO-UHFFFAOYSA-N 2-(4-methyl-6,7,8,9-tetrahydro-5h-cyclohepta[d]pyrimidin-2-yl)guanidine Chemical compound C1CCCCC2=C1N=C(NC(N)=N)N=C2C NIULILZCZJKURO-UHFFFAOYSA-N 0.000 claims 1
- VVUHTEPXYZVIAU-UHFFFAOYSA-N 2-(4-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-2-yl)guanidine Chemical compound CC1=NC(NC(N)=N)=NC2=C1CCC2 VVUHTEPXYZVIAU-UHFFFAOYSA-N 0.000 claims 1
- KDKLJCVVZFYRKV-UHFFFAOYSA-N 2-(4-methyl-6-phenyl-5,6,7,8-tetrahydroquinazolin-2-yl)guanidine Chemical compound C1C=2C(C)=NC(NC(N)=N)=NC=2CCC1C1=CC=CC=C1 KDKLJCVVZFYRKV-UHFFFAOYSA-N 0.000 claims 1
- ZXRRRMMSIMSGTN-UHFFFAOYSA-N 2-(4-methyl-6-propan-2-yl-5,6,7,8-tetrahydroquinazolin-2-yl)guanidine Chemical compound NC(=N)NC1=NC(C)=C2CC(C(C)C)CCC2=N1 ZXRRRMMSIMSGTN-UHFFFAOYSA-N 0.000 claims 1
- IWTUDKQIQBGRFW-UHFFFAOYSA-N 2-(4-methyl-6-propyl-5,6,7,8-tetrahydroquinazolin-2-yl)guanidine Chemical compound NC(=N)NC1=NC(C)=C2CC(CCC)CCC2=N1 IWTUDKQIQBGRFW-UHFFFAOYSA-N 0.000 claims 1
- NWMKMGDIVMWXAX-UHFFFAOYSA-N 2-(4-methyl-8-phenyl-5,6,7,8-tetrahydroquinazolin-2-yl)guanidine Chemical compound C1CCC=2C(C)=NC(NC(N)=N)=NC=2C1C1=CC=CC=C1 NWMKMGDIVMWXAX-UHFFFAOYSA-N 0.000 claims 1
- CWWOITPDZXNTSJ-UHFFFAOYSA-N 2-(5,6,7,8-tetrahydroquinolin-2-yl)guanidine Chemical compound C1CCCC2=NC(NC(=N)N)=CC=C21 CWWOITPDZXNTSJ-UHFFFAOYSA-N 0.000 claims 1
- IJKMBMJUQLLNQO-UHFFFAOYSA-N 2-(5,6,7,8-tetrahydroquinoxalin-2-yl)guanidine Chemical compound C1CCCC2=NC(NC(=N)N)=CN=C21 IJKMBMJUQLLNQO-UHFFFAOYSA-N 0.000 claims 1
- MOMBHZPOPKWDCA-UHFFFAOYSA-N 2-(6-phenyl-5,6,7,8-tetrahydro-1,2,4-benzotriazin-3-yl)guanidine Chemical compound C1C2=NC(NC(=N)N)=NN=C2CCC1C1=CC=CC=C1 MOMBHZPOPKWDCA-UHFFFAOYSA-N 0.000 claims 1
- QFZUFBREJJYXLW-UHFFFAOYSA-N 2-(6-phenyl-5,6,7,8-tetrahydroquinolin-2-yl)guanidine Chemical compound C1CC2=NC(NC(=N)N)=CC=C2CC1C1=CC=CC=C1 QFZUFBREJJYXLW-UHFFFAOYSA-N 0.000 claims 1
- IIZDBUQDDYDOEV-UHFFFAOYSA-N 2-(6-phenyl-5,6,7,8-tetrahydroquinoxalin-2-yl)guanidine Chemical compound C1CC2=NC(NC(=N)N)=CN=C2CC1C1=CC=CC=C1 IIZDBUQDDYDOEV-UHFFFAOYSA-N 0.000 claims 1
- YDHAPKSUPXKXQA-UHFFFAOYSA-N 2-(6-propan-2-yl-5,6,7,8-tetrahydroquinazolin-2-yl)guanidine Chemical compound NC(=N)NC1=NC=C2CC(C(C)C)CCC2=N1 YDHAPKSUPXKXQA-UHFFFAOYSA-N 0.000 claims 1
- SANNPHRRXQXGBH-UHFFFAOYSA-N 2-(6-propyl-5,6,7,8-tetrahydroquinazolin-2-yl)guanidine Chemical compound NC(=N)NC1=NC=C2CC(CCC)CCC2=N1 SANNPHRRXQXGBH-UHFFFAOYSA-N 0.000 claims 1
- ASOOANNKZUSTMO-UHFFFAOYSA-N 2-(6-tert-butyl-4-methyl-5,6,7,8-tetrahydroquinazolin-2-yl)guanidine Chemical compound C1CC(C(C)(C)C)CC2=C1N=C(NC(N)=N)N=C2C ASOOANNKZUSTMO-UHFFFAOYSA-N 0.000 claims 1
- OSXJUJDGUHKTJQ-UHFFFAOYSA-N 2-(6-tert-butyl-5,6,7,8-tetrahydroquinazolin-2-yl)guanidine Chemical compound NC(=N)NC1=NC=C2CC(C(C)(C)C)CCC2=N1 OSXJUJDGUHKTJQ-UHFFFAOYSA-N 0.000 claims 1
- KMPYHOTXRHIQTQ-UHFFFAOYSA-N 2-(7-phenyl-5,6,7,8-tetrahydro-1,2,4-benzotriazin-3-yl)guanidine Chemical compound C1CC2=NC(NC(=N)N)=NN=C2CC1C1=CC=CC=C1 KMPYHOTXRHIQTQ-UHFFFAOYSA-N 0.000 claims 1
- TVFFYWZXKFWYAR-UHFFFAOYSA-N 2-(7-phenyl-5,6,7,8-tetrahydroquinoxalin-2-yl)guanidine Chemical compound C1C2=NC(NC(=N)N)=CN=C2CCC1C1=CC=CC=C1 TVFFYWZXKFWYAR-UHFFFAOYSA-N 0.000 claims 1
- MRFZBGDHMXHWBR-UHFFFAOYSA-N 2-(8-butan-2-yl-4-methyl-5,6,7,8-tetrahydroquinazolin-2-yl)guanidine Chemical compound N1=C(NC(N)=N)N=C2C(C(C)CC)CCCC2=C1C MRFZBGDHMXHWBR-UHFFFAOYSA-N 0.000 claims 1
- YIFCRDLYZJGGJW-UHFFFAOYSA-N 2-(8-tert-butyl-4-methyl-5,6,7,8-tetrahydroquinazolin-2-yl)guanidine Chemical compound CC(C)(C)C1CCCC2=C1N=C(NC(N)=N)N=C2C YIFCRDLYZJGGJW-UHFFFAOYSA-N 0.000 claims 1
- OFXMDUCSFGSEME-UHFFFAOYSA-N 2-[4-methyl-6-(2-methylbutan-2-yl)-5,6,7,8-tetrahydroquinazolin-2-yl]guanidine Chemical compound NC(=N)NC1=NC(C)=C2CC(C(C)(C)CC)CCC2=N1 OFXMDUCSFGSEME-UHFFFAOYSA-N 0.000 claims 1
- UTTPPNFLOYXXBU-UHFFFAOYSA-N 2-[6-phenyl-4-(trifluoromethyl)-5,6,7,8-tetrahydroquinazolin-2-yl]guanidine Chemical compound C1C=2C(C(F)(F)F)=NC(NC(=N)N)=NC=2CCC1C1=CC=CC=C1 UTTPPNFLOYXXBU-UHFFFAOYSA-N 0.000 claims 1
- FPTNCEKIDSBEQH-UHFFFAOYSA-N 2-[6-propan-2-yl-4-(trifluoromethyl)-5,6,7,8-tetrahydroquinazolin-2-yl]guanidine Chemical compound NC(=N)NC1=NC(C(F)(F)F)=C2CC(C(C)C)CCC2=N1 FPTNCEKIDSBEQH-UHFFFAOYSA-N 0.000 claims 1
- DJAZRDWUHJGBPP-UHFFFAOYSA-N 2-[6-tert-butyl-4-(trifluoromethyl)-5,6,7,8-tetrahydroquinazolin-2-yl]guanidine Chemical compound NC(=N)NC1=NC(C(F)(F)F)=C2CC(C(C)(C)C)CCC2=N1 DJAZRDWUHJGBPP-UHFFFAOYSA-N 0.000 claims 1
- GBCUUAHMGWGOBZ-UHFFFAOYSA-N 2-[8-(2-cyanoethyl)-4-methyl-5,6,7,8-tetrahydroquinazolin-2-yl]guanidine Chemical compound N#CCCC1CCCC2=C1N=C(NC(N)=N)N=C2C GBCUUAHMGWGOBZ-UHFFFAOYSA-N 0.000 claims 1
- WKDHNQZWNUOOAE-UHFFFAOYSA-N 2-[8-(cyclohexen-1-yl)-4-methyl-5,6,7,8-tetrahydroquinazolin-2-yl]guanidine Chemical compound C1CCC=2C(C)=NC(NC(N)=N)=NC=2C1C1=CCCCC1 WKDHNQZWNUOOAE-UHFFFAOYSA-N 0.000 claims 1
- FEAVXMPFTQROEI-UHFFFAOYSA-N 2h-pyrano[3,2-b]pyridine Chemical class C1=CN=C2C=CCOC2=C1 FEAVXMPFTQROEI-UHFFFAOYSA-N 0.000 claims 1
- HWMHJXWJAFSWLI-UHFFFAOYSA-N 5,6,7,8,9,10-hexahydrocycloocta[b]pyrazine Chemical class C1CCCCCC2=NC=CN=C21 HWMHJXWJAFSWLI-UHFFFAOYSA-N 0.000 claims 1
- ZCXXDEJQLTXXJL-UHFFFAOYSA-N 5,6,7,8,9,10-hexahydrocycloocta[b]pyridine Chemical compound C1CCCCCC2=NC=CC=C21 ZCXXDEJQLTXXJL-UHFFFAOYSA-N 0.000 claims 1
- KTQHWAJUEUKKIQ-UHFFFAOYSA-N 5,6,7,8,9,10-hexahydrocycloocta[d]pyrimidine Chemical compound C1CCCCCC2=NC=NC=C21 KTQHWAJUEUKKIQ-UHFFFAOYSA-N 0.000 claims 1
- CCUFGPZYNXQGQP-UHFFFAOYSA-N 5,6,7,8,9,10-hexahydrocycloocta[e][1,2,4]triazine Chemical compound C1CCCCCC2=NN=CN=C21 CCUFGPZYNXQGQP-UHFFFAOYSA-N 0.000 claims 1
- OZVFKYKYLIUQKB-UHFFFAOYSA-N 5,6,7,8-tetrahydro-1,2,4-benzotriazine Chemical compound N1=CN=C2CCCCC2=N1 OZVFKYKYLIUQKB-UHFFFAOYSA-N 0.000 claims 1
- PWFXESTVPWRTTI-UHFFFAOYSA-N 5,6,7,8-tetrahydropyrido[2,3-b]pyrazine Chemical class C1=CN=C2CCCNC2=N1 PWFXESTVPWRTTI-UHFFFAOYSA-N 0.000 claims 1
- VRUDHVVJIWFTGM-UHFFFAOYSA-N 5,6,7,8-tetrahydropyrido[3,2-d]pyrimidine Chemical group N1=CN=C2CCCNC2=C1 VRUDHVVJIWFTGM-UHFFFAOYSA-N 0.000 claims 1
- SMRANQIZWRLADG-UHFFFAOYSA-N 5,6,7,8-tetrahydropyrido[3,4-e][1,2,4]triazine Chemical compound N1=CN=C2CNCCC2=N1 SMRANQIZWRLADG-UHFFFAOYSA-N 0.000 claims 1
- SMSHIXOEBWOYJS-UHFFFAOYSA-N 5,6,7,8-tetrahydroquinazoline Chemical compound C1=NC=C2CCCCC2=N1 SMSHIXOEBWOYJS-UHFFFAOYSA-N 0.000 claims 1
- YQDGQEKUTLYWJU-UHFFFAOYSA-N 5,6,7,8-tetrahydroquinoline Chemical compound C1=CC=C2CCCCC2=N1 YQDGQEKUTLYWJU-UHFFFAOYSA-N 0.000 claims 1
- VSDKQJCLORTLFK-UHFFFAOYSA-N 5h-cyclohepta[d]pyrimidine Chemical compound C1C=CC=CC2=NC=NC=C12 VSDKQJCLORTLFK-UHFFFAOYSA-N 0.000 claims 1
- KYXLYJWGRDSBIK-UHFFFAOYSA-N 5h-pyrido[3,2-b]azepine Chemical class N1C=CC=CC2=NC=CC=C12 KYXLYJWGRDSBIK-UHFFFAOYSA-N 0.000 claims 1
- DQGCNIVDCDKADB-UHFFFAOYSA-N 5h-pyrimido[5,4-b]azepine Chemical compound N1C=CC=CC2=NC=NC=C12 DQGCNIVDCDKADB-UHFFFAOYSA-N 0.000 claims 1
- HFTVJMFWJUFBNO-UHFFFAOYSA-N 5h-pyrrolo[2,3-b]pyrazine Chemical compound C1=CN=C2NC=CC2=N1 HFTVJMFWJUFBNO-UHFFFAOYSA-N 0.000 claims 1
- HEOQXHNKRXRCTO-UHFFFAOYSA-N 6,7,8,9-tetrahydro-5h-benzo[7]annulene Chemical compound C1CCCCC2=CC=CC=C21 HEOQXHNKRXRCTO-UHFFFAOYSA-N 0.000 claims 1
- PHSUSFYECUVJDN-UHFFFAOYSA-N 6,7,8,9-tetrahydro-5h-cyclohepta[e][1,2,4]triazine Chemical compound C1CCCCC2=NC=NN=C21 PHSUSFYECUVJDN-UHFFFAOYSA-N 0.000 claims 1
- WCTDRGQIEULRBE-UHFFFAOYSA-N 6,7-dihydro-5h-cyclopenta[b]pyrazine Chemical compound C1=CN=C2CCCC2=N1 WCTDRGQIEULRBE-UHFFFAOYSA-N 0.000 claims 1
- BJUPTJXRJDXLHF-UHFFFAOYSA-N 6,7-dihydro-5h-cyclopenta[d]pyrimidine Chemical compound N1=CN=C2CCCC2=C1 BJUPTJXRJDXLHF-UHFFFAOYSA-N 0.000 claims 1
- MVAITNYCRJFGKK-UHFFFAOYSA-N 6,7-dihydro-5h-cyclopenta[e][1,2,4]triazine Chemical compound C1=NN=C2CCCC2=N1 MVAITNYCRJFGKK-UHFFFAOYSA-N 0.000 claims 1
- IKODPGBBYKAAFB-UHFFFAOYSA-N 6,7-dihydro-5h-pyrrolo[2,3-b]pyrazine Chemical class C1=CN=C2NCCC2=N1 IKODPGBBYKAAFB-UHFFFAOYSA-N 0.000 claims 1
- LMAYDNVIKBCSLP-UHFFFAOYSA-N 6,7-dihydro-5h-pyrrolo[3,2-d]pyrimidine Chemical compound C1=NC=C2NCCC2=N1 LMAYDNVIKBCSLP-UHFFFAOYSA-N 0.000 claims 1
- HZZDSZSOINWYNZ-UHFFFAOYSA-N 6,7-dihydro-5h-pyrrolo[3,4-e][1,2,4]triazine Chemical compound N1=CN=C2CNCC2=N1 HZZDSZSOINWYNZ-UHFFFAOYSA-N 0.000 claims 1
- XAAILTGRFRYWMY-UHFFFAOYSA-N 6h-pyrano[2,3-b]pyrazine Chemical compound C1=CN=C2C=CCOC2=N1 XAAILTGRFRYWMY-UHFFFAOYSA-N 0.000 claims 1
- LXJWTBIPBFBGFV-UHFFFAOYSA-N 6h-pyrano[3,2-d]pyrimidine Chemical compound N1=CN=C2C=CCOC2=C1 LXJWTBIPBFBGFV-UHFFFAOYSA-N 0.000 claims 1
- PHQVXPYZZSPBHC-UHFFFAOYSA-N 6h-thiopyrano[3,2-d]pyrimidine Chemical compound N1=CN=C2C=CCSC2=C1 PHQVXPYZZSPBHC-UHFFFAOYSA-N 0.000 claims 1
- OJPNRMUYCVNKAS-UHFFFAOYSA-N 9h-cyclohepta[b]pyrazine Chemical class C1C=CC=CC2=NC=CN=C12 OJPNRMUYCVNKAS-UHFFFAOYSA-N 0.000 claims 1
- 206010012335 Dependence Diseases 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 208000004454 Hyperalgesia Diseases 0.000 claims 1
- 208000035154 Hyperesthesia Diseases 0.000 claims 1
- 102000011015 Neuropeptide FF receptor Human genes 0.000 claims 1
- 108010061550 Neuropeptide FF receptor Proteins 0.000 claims 1
- 206010057852 Nicotine dependence Diseases 0.000 claims 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 claims 1
- 208000025569 Tobacco Use disease Diseases 0.000 claims 1
- 206010046543 Urinary incontinence Diseases 0.000 claims 1
- 206010048010 Withdrawal syndrome Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 claims 1
- 125000000278 alkyl amino alkyl group Chemical group 0.000 claims 1
- 125000004949 alkyl amino carbonyl amino group Chemical group 0.000 claims 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims 1
- 125000004947 alkyl aryl amino group Chemical group 0.000 claims 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims 1
- 125000004687 alkyl sulfinyl alkyl group Chemical group 0.000 claims 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims 1
- 125000004688 alkyl sulfonyl alkyl group Chemical group 0.000 claims 1
- 125000004422 alkyl sulphonamide group Chemical group 0.000 claims 1
- 125000006350 alkyl thio alkyl group Chemical group 0.000 claims 1
- 125000005530 alkylenedioxy group Chemical group 0.000 claims 1
- 125000000266 alpha-aminoacyl group Chemical group 0.000 claims 1
- 125000004103 aminoalkyl group Chemical group 0.000 claims 1
- 125000005097 aminocarbonylalkyl group Chemical group 0.000 claims 1
- 125000005018 aryl alkenyl group Chemical group 0.000 claims 1
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 claims 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 1
- 125000005100 aryl amino carbonyl group Chemical group 0.000 claims 1
- 125000001769 aryl amino group Chemical group 0.000 claims 1
- 125000005160 aryl oxy alkyl group Chemical group 0.000 claims 1
- 125000005135 aryl sulfinyl group Chemical group 0.000 claims 1
- 125000004421 aryl sulphonamide group Chemical group 0.000 claims 1
- 125000005110 aryl thio group Chemical group 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 150000007514 bases Chemical class 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims 1
- 230000036772 blood pressure Effects 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 125000004181 carboxyalkyl group Chemical group 0.000 claims 1
- 230000001276 controlling effect Effects 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000004966 cyanoalkyl group Chemical group 0.000 claims 1
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 claims 1
- 125000005167 cycloalkylaminocarbonyl group Chemical group 0.000 claims 1
- PAADHXDWLFDAON-UHFFFAOYSA-N cycloocta[b]pyridine Chemical class C1=CC=CC=CC2=CC=CN=C21 PAADHXDWLFDAON-UHFFFAOYSA-N 0.000 claims 1
- HJXKACHFFVNTKR-UHFFFAOYSA-N cycloocta[d]pyrimidine Chemical compound C1=CC=CC=CC2=NC=NC=C21 HJXKACHFFVNTKR-UHFFFAOYSA-N 0.000 claims 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 claims 1
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 claims 1
- 125000004986 diarylamino group Chemical group 0.000 claims 1
- 239000003792 electrolyte Substances 0.000 claims 1
- 230000008030 elimination Effects 0.000 claims 1
- 238000003379 elimination reaction Methods 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 claims 1
- 230000037406 food intake Effects 0.000 claims 1
- 235000012631 food intake Nutrition 0.000 claims 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 1
- 125000004967 formylalkyl group Chemical group 0.000 claims 1
- YRTCKZIKGWZNCU-UHFFFAOYSA-N furo[3,2-b]pyridine Chemical class C1=CC=C2OC=CC2=N1 YRTCKZIKGWZNCU-UHFFFAOYSA-N 0.000 claims 1
- 150000002357 guanidines Chemical class 0.000 claims 1
- 229940083094 guanine derivative acting on arteriolar smooth muscle Drugs 0.000 claims 1
- 125000004992 haloalkylamino group Chemical group 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000005241 heteroarylamino group Chemical group 0.000 claims 1
- 125000005222 heteroarylaminocarbonyl group Chemical group 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 150000004677 hydrates Chemical class 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
- 230000003914 insulin secretion Effects 0.000 claims 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000006386 memory function Effects 0.000 claims 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 1
- 125000006257 n-butyloxycarbonyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])OC(*)=O 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 claims 1
- 230000000506 psychotropic effect Effects 0.000 claims 1
- 150000003222 pyridines Chemical class 0.000 claims 1
- YEYHFKBVNARCNE-UHFFFAOYSA-N pyrido[2,3-b]pyrazine Chemical compound N1=CC=NC2=CC=CN=C21 YEYHFKBVNARCNE-UHFFFAOYSA-N 0.000 claims 1
- BWESROVQGZSBRX-UHFFFAOYSA-N pyrido[3,2-d]pyrimidine Chemical compound C1=NC=NC2=CC=CN=C21 BWESROVQGZSBRX-UHFFFAOYSA-N 0.000 claims 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 claims 1
- 239000002464 receptor antagonist Substances 0.000 claims 1
- 229940044551 receptor antagonist Drugs 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- FCQQCBRXKJOFAV-UHFFFAOYSA-N tert-butyl 2-(diaminomethylideneamino)-4-methyl-7,8-dihydro-5h-pyrido[4,3-d]pyrimidine-6-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CC2=C1N=C(NC(N)=N)N=C2C FCQQCBRXKJOFAV-UHFFFAOYSA-N 0.000 claims 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- YJSKZIATOGOJEB-UHFFFAOYSA-N thieno[2,3-b]pyrazine Chemical compound C1=CN=C2SC=CC2=N1 YJSKZIATOGOJEB-UHFFFAOYSA-N 0.000 claims 1
- DBDCNCCRPKTRSD-UHFFFAOYSA-N thieno[3,2-b]pyridine Chemical class C1=CC=C2SC=CC2=N1 DBDCNCCRPKTRSD-UHFFFAOYSA-N 0.000 claims 1
- 239000002175 thienopyridine Chemical class 0.000 claims 1
- 229940125670 thienopyridine Drugs 0.000 claims 1
- 125000003396 thiol group Chemical class [H]S* 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH15262003 | 2003-09-05 | ||
| PCT/CH2004/000556 WO2005023781A1 (de) | 2003-09-05 | 2004-09-03 | Guanidinderivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007504176A JP2007504176A (ja) | 2007-03-01 |
| JP2007504176A5 true JP2007504176A5 (enExample) | 2007-10-11 |
Family
ID=34230846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006525025A Pending JP2007504176A (ja) | 2003-09-05 | 2004-09-03 | グアニジン誘導体 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7544691B2 (enExample) |
| EP (1) | EP1663993B1 (enExample) |
| JP (1) | JP2007504176A (enExample) |
| KR (1) | KR20060064065A (enExample) |
| CN (1) | CN1845907B (enExample) |
| AT (1) | ATE388943T1 (enExample) |
| AU (1) | AU2004270304A1 (enExample) |
| BR (1) | BRPI0414103A (enExample) |
| CA (1) | CA2536927A1 (enExample) |
| DE (1) | DE502004006515D1 (enExample) |
| ES (1) | ES2300807T3 (enExample) |
| IL (1) | IL173853A0 (enExample) |
| NO (1) | NO20061531L (enExample) |
| PL (1) | PL1663993T3 (enExample) |
| RU (1) | RU2006110738A (enExample) |
| WO (1) | WO2005023781A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE521512C2 (sv) | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
| ES2708552T3 (es) | 2002-12-20 | 2019-04-10 | Niconovum Ab | Método para la preparación de un material particulado que contiene nicotina con una celulosa cristalina (en particular MCC) |
| WO2007104573A2 (en) | 2006-03-16 | 2007-09-20 | Niconovum Ab | Improved snuff composition |
| CN102665406B (zh) * | 2009-12-24 | 2016-03-09 | 诺沃梅尔公司 | 合成多环胍化合物的方法 |
| WO2015002150A1 (ja) | 2013-07-03 | 2015-01-08 | 株式会社新日本科学 | 新規化合物，有機カチオントランスポーター３の検出剤及び活性阻害剤 |
| WO2018152134A1 (en) | 2017-02-14 | 2018-08-23 | Research Triangle Institute | Proline-based neuropeptide ff receptor modulators |
| CN108159032A (zh) * | 2018-01-24 | 2018-06-15 | 昆明理工大学 | 二甲双胍在制备预防和/或治疗阿片类毒品成瘾药物中的应用和药物及制备方法 |
| CN108159031A (zh) * | 2018-01-24 | 2018-06-15 | 昆明理工大学 | 二甲双胍在制备预防和/或治疗苯丙胺类毒品成瘾药物中的应用和药物及制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3505327A (en) | 1967-08-07 | 1970-04-07 | American Cyanamid Co | Tetrahydroquinoxalinyl phosphates or thiophosphates |
| BE795257A (fr) | 1972-02-10 | 1973-08-09 | Thomae Gmbh Dr K | Nouveaux oxazols |
| DE3334455A1 (de) * | 1983-03-04 | 1984-09-06 | Bayer Ag, 5090 Leverkusen | Guanidin - derivate |
| WO2003026667A1 (en) * | 2001-09-24 | 2003-04-03 | Synaptic Pharmaceutical Corporation | Quinazolino- and quinolino- guanidines as ligands for the neurop eptide ff (npff) receptors |
| WO2003026657A1 (en) * | 2001-09-24 | 2003-04-03 | Synaptic Pharmaceutical Corporation | Compounds for the treatment of pain |
| US20030139431A1 (en) * | 2001-09-24 | 2003-07-24 | Kawakami Joel K. | Guanidines which are agonist/antagonist ligands for neuropeptide FF (NPFF) receptors |
-
2004
- 2004-09-03 JP JP2006525025A patent/JP2007504176A/ja active Pending
- 2004-09-03 CA CA002536927A patent/CA2536927A1/en not_active Abandoned
- 2004-09-03 BR BRPI0414103-2A patent/BRPI0414103A/pt not_active IP Right Cessation
- 2004-09-03 DE DE502004006515T patent/DE502004006515D1/de not_active Expired - Lifetime
- 2004-09-03 AU AU2004270304A patent/AU2004270304A1/en not_active Abandoned
- 2004-09-03 WO PCT/CH2004/000556 patent/WO2005023781A1/de not_active Ceased
- 2004-09-03 US US10/570,517 patent/US7544691B2/en not_active Expired - Fee Related
- 2004-09-03 CN CN2004800253298A patent/CN1845907B/zh not_active Expired - Fee Related
- 2004-09-03 ES ES04761896T patent/ES2300807T3/es not_active Expired - Lifetime
- 2004-09-03 RU RU2006110738/04A patent/RU2006110738A/ru not_active Application Discontinuation
- 2004-09-03 KR KR1020067004345A patent/KR20060064065A/ko not_active Withdrawn
- 2004-09-03 EP EP04761896A patent/EP1663993B1/de not_active Expired - Lifetime
- 2004-09-03 PL PL04761896T patent/PL1663993T3/pl unknown
- 2004-09-03 AT AT04761896T patent/ATE388943T1/de not_active IP Right Cessation
-
2006
- 2006-02-21 IL IL173853A patent/IL173853A0/en unknown
- 2006-04-04 NO NO20061531A patent/NO20061531L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2015353210B2 (en) | 2-aminopyrimidine compound and pharmaceutical composition and use thereof | |
| JP2005503345A5 (enExample) | ||
| RU2019120986A (ru) | Фармацевтическая комбинация, содержащая ингибитор alk и ингибитор shp2 | |
| RU2009134044A (ru) | Ингибиторы фосфатидилинозитол-3-киназы | |
| US20180258072A1 (en) | Quinoline derivative | |
| JP2020505395A5 (enExample) | ||
| JP2005538062A5 (enExample) | ||
| JP2018533611A5 (enExample) | ||
| JP2003512467A5 (enExample) | ||
| RU2004139111A (ru) | Новые конденсированные производные имидазола | |
| JP2016530283A5 (enExample) | ||
| IL176469A (en) | Phenylalanine derivatives | |
| RU2009123930A (ru) | Химические соединения 637: пиридопиримидиндионы в качестве ингибиторов pde4 | |
| PE20090944A1 (es) | PIRIMIDINAS BICICLICAS FUSIONADAS COMO INHIBIDORES DE LA VIA Pi3K/AKT | |
| JP2018522852A5 (enExample) | ||
| JP2009532504A5 (enExample) | ||
| MXPA04002338A (es) | Derivados de carbazol y su uso como antagonistas receptores del npy5. | |
| WO2007056215A2 (en) | N-aryl-thienopyrimidin-4-amines and the use thereof | |
| RU2007134105A (ru) | Производные 4-оксохиназолин-3-ил-бензамида для лечения цитокиновых заболеваний | |
| JP2007504176A5 (enExample) | ||
| ATE375984T1 (de) | Chinazolin derivate | |
| JP2015515995A (ja) | キナーゼ阻害剤として有用な置換アミノキナゾリン | |
| Kamel et al. | Synthetic approaches and potential bioactivity of different functionalized quinazoline and quinazolinone scaffolds | |
| JP2005513020A5 (enExample) | ||
| RU2001128671A (ru) | Тиенопиримидиновые производные, их получение и применение |